Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Rapid advice guidelines for the pharmacological management of ha in patients with liver cirrhosis
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Poster
- By: LI, Huibo (peking univercity third hospital)
- Co-author(s): Huibo Li
BackgroundHuman albumin (HA) is widely used in hepatology due to support from international scientific societies for the treatment or prevention of severe complications in cirrhosis. However, no formal guidelines exist regarding its use in China, and in many clinical situations, limited evidence is available due to its high cost and the use of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019